GALEN ATLANTICA - Key Persons
Job Titles:
- System - Wide Initiatives
Carolyn Easton has over 20 years of experience as a biomedical information research specialist, including positions as a Medical Information Specialist at UnitedHealth Group and as a Senior Research Scientist at General Mills. Carolyn was trained as a pharmacist and in library and information science.
With 30+ years of experience in Washington DC, Paul Kim advises patient advocates, global life science leaders, and innovative emerging companies on FDA and public health policy. Paul's experience extends across drug and device law; rare disease innovation; public health and immunization policy; biodefense policy; and congressional oversight & investigations. He most recently co-chaired the FDA practice of a life sciences-focused international law firm.
Job Titles:
- Scientist
- Global Public Health & Pandemic Preparedness
Danelle Miller's unique career spans 25 years of legal, regulatory and policy experience across the diagnostic and digital health domains. She combines her background as a regulatory lawyer, policy strategist, and compliance leader with a track-record of successful engagement including the United States Congress, the FDA, and their respective global counterparts. She was most recently the Vice President for Global Regulatory Policy & Intelligence at Roche Diagnostics.
Celine Gurry is an infectious disease scientist and epidemiologist, focusing on epidemic preparedness, surveillance and response to emerging viruses. Currently based out of Geneva, she has previously held positions with Coalition for Epidemic Preparedness Innovations, Médecins Sans Frontières, and the World Health Organization.
Dr. Pezalla is a strategic payer consultant advising biopharmaceutical firms on market access, technology assessment, and drug evaluation in the US market. His clients include established pharmaceutical firms and emerging companies with innovative therapies including immune-oncology, cell and
Cherie McNett's over 20 years of experience in government relations have endowed her with in-depth knowledge of healthcare payment systems, the components of reimbursement, and how they are both established and implemented within the federal regulatory process. After working for Congress and State Government, Cherie held positions as a Director of Health Policy for the American Academy of Ophthalmology and the Director of Government Affairs at the American Urological Association.
Carolyn Easton has over 20 years of experience as a biomedical information research specialist, including positions as a Medical Information Specialist at UnitedHealth Group and as a Senior Research Scientist at General Mills. Carolyn was trained as a pharmacist and in library and information science.
Ginger Myers is a senior at Wake Forest University majoring in Politics and International Affairs and Philosophy. She has worked for lobbying firms, patient advocacy groups, and gene therapy companies within both policy and legal teams.
Job Titles:
- Consultant
- Value & Reimbursement
Dr. Pezalla is a strategic payer consultant advising biopharmaceutical firms on market access, technology assessment, and drug evaluation in the US market. His clients include established pharmaceutical firms and emerging companies with innovative therapies including immune-oncology, cell and
With 30+ years of experience in Washington DC, Paul Kim advises patient advocates, global life science leaders, and innovative emerging companies on FDA and public health policy. Paul's experience extends across drug and device law; rare disease innovation; public health and immunization policy; biodefense policy; and congressional oversight & investigations. He most recently co-chaired the FDA practice of a life sciences-focused international law firm.
Ginger Myers is a senior at Wake Forest University majoring in Politics and International Affairs and Philosophy. She has worked for lobbying firms, patient advocacy groups, and gene therapy companies within both policy and legal teams.
"Who will these new professionals be? What will they look like? Well, they will look more like Matt and Nicholas than a ‘graduate' of P&G. Yes, they will have all the tools of segmentation and pricing and strong analytical capabilities. They will need to start with the same basic checklist that McKinsey published. But they will also have some experience with social and regulatory policy as both Matt and Nicholas do. They will need to have worked in places like Washington and Brussels and have a feel for the sausage-making process of policy. Most importantly, they will have empathy - the ability to put themselves into the shoes of others."
Testimonial by Bill Matassoni, former head of marketing at BCG and McKinsey, founder of The McKinsey Quarterly, and author of Marketing Saves the World (2020).
Nicholas is excited by developing the strategies and partnerships that enable frontier technologies to transform economies, health systems and patient lives. A Washington lawyer turned international strategy consultant, he brings to his client work an intellectual rigor honed at Latham & Watkins and McKinsey along with the ability to engage hearts and minds. A graduate of MIT and Harvard Law School, Nicholas is an aspiring global citizen who splits his time between the United States and Europe.
Cherie McNett's over 20 years of experience in government relations have endowed her with in-depth knowledge of healthcare payment systems, the components of reimbursement, and how they are both established and implemented within the federal regulatory process. After working for Congress and State Government, Cherie held positions as a Director of Health Policy for the American Academy of Ophthalmology and the Director of Government Affairs at the American Urological Association.
Celine Gurry is an infectious disease scientist and epidemiologist, focusing on epidemic preparedness, surveillance and response to emerging viruses. Currently based out of Geneva, she has previously held positions with Coalition for Epidemic Preparedness Innovations, Médecins Sans Frontières, and the World Health Organization.